First cell gene therapy to treat “Bubble boy” disease has been legalised in Europe

Last July, an article was published in medical journal Blood, which described the success of a cell gene therapy modality to treat the immunodeficiency caused by adenosine deaminase deficiency – “Bubble boy” disease. This is a disease that alters purine...

New advances and challenges in the production of human-animal chimeras

They had overcome the obstacle of using human embryonic stem cells, but that even so, a ethical difficulty remained with the producing organs formed almost entirely of human cells in experimental animals. It seems a little excessive that, in less than two months, we have...